Impact of surface area of silica particles on dissolution rate and oral bioavailability of poorly water soluble drugs: A case study with aceclofenac

International Journal of Pharmaceutics

Volumn 461, Issue 1-2, 2014, Pages 459-468

  Kumar, Dinesh ^a   Sailaja Chirravuri, S V ^a   Shastri, Nalini R ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

Aceclofenac; Drug release mechanism; MCM 41; Mesoporous silica; Non porous silica

Indexed keywords

ACECLOFENAC; IBUPROFEN; SILICON DIOXIDE; DICLOFENAC; DRUG CARRIER; NONSTEROID ANTIINFLAMMATORY AGENT; SOLVENT; TABLET; WATER;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DESORPTION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG ADSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG RELEASE; DRUG SOLUBILITY; DRUG STABILITY; EVAPORATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INFRARED SPECTROSCOPY; MALE; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PLASMA CONCENTRATION-TIME CURVE; POROSITY; PRIORITY JOURNAL; RAT; SURFACE PROPERTY; TIME TO MAXIMUM PLASMA CONCENTRATION; X RAY DIFFRACTION; ANALOGS AND DERIVATIVES; ANIMAL; BIOAVAILABILITY; CHEMISTRY; COMPARATIVE STUDY; MEDICINAL CHEMISTRY; ORAL DRUG ADMINISTRATION; PARTICLE SIZE; PROCEDURES; SOLUBILITY; TABLET; WISTAR RAT;

ADMINISTRATION, ORAL; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIOLOGICAL AVAILABILITY; CALORIMETRY, DIFFERENTIAL SCANNING; CHEMISTRY, PHARMACEUTICAL; DICLOFENAC; DRUG CARRIERS; MALE; PARTICLE SIZE; POROSITY; RATS; RATS, WISTAR; SILICON DIOXIDE; SOLUBILITY; SOLVENTS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TABLETS; WATER; X-RAY DIFFRACTION;

EID: 84891712915     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2013.12.017     Document Type: Article

References (44)

1. A. Alvarez-Larena, J. Piniella, E. Carrasco, A. Ginebreda, S. Julia, and G. Germain Crystal structure and spectroscopic study of 2-[(2,6-dichlorophenyl) amino] phenylacetoxyacetic acid (aceclofenac) J. Chem. Crystallogr. 22 1992 323 328
2. V. Ambrogi, L. Perioli, F. Marmottini, O. Accorsi, C. Pagano, M. Ricci, and C. Rossi Role of mesoporous silicates on carbamazepine dissolution rate enhancement Microporous Mesoporous Mater. 113 2008 445 452
3. S. Angelos, M. Liong, E. Choi, and J.I. Zink Mesoporous silicate materials as substrates for molecular machines and drug delivery Chem. Eng. J. 137 2008 4 13 (Pubitemid 351226627)
4. H.C. Ansel, N.G. Popovich, and L.V. Allen Pharmaceutical Dosage Forms and Drug Delivery Systems 1990 Lea & Febiger Philadelphia
5. T. Azaïs, C. Tourné-Péteilh, F. Aussenac, N. Baccile, C. Coelho, J.M. Devoisselle, and F. Babonneau Solid-state NMR study of ibuprofen confined in MCM-41 material Chem. Mater. 18 2006 6382 6390 (Pubitemid 46132802)
6. B.A. Bagul, R.R. Shah, D.S. Ghodke, S.S. Patil, and D.D. Chougule Physicochemical characterization and enhancement of oral bioavailability of aceclofenac: Gelucire 14/44 solid dispersion Iran. J. Pharm. Sci. 6 2010 235 242
7. J.S. Beck, J.C. Vartuli, W.J. Roth, M.E. Leonowicz, C.T. Kresge, K.D. Schmitt, C.T.W. Chu, D.H. Olson, and E.W. Sheppard A new family of mesoporous molecular sieves prepared with liquid crystal templates J. Am. Chem. Soc. 114 1992 10834 10843
8. Y. Belmabkhout, and A. Sayari Effect of pore expansion and amine functionalization of mesoporous silica on CO2 adsorption over a wide range of conditions Adsorption 15 2009 318 328
9. J. Bhinge, R. Kumar, and V. Sinha A simple and sensitive stability-indicating RP-HPLC assay method for the determination of aceclofenac J. Chromatogr. Sci. 46 2008 440 444 (Pubitemid 351669009)
10. R. Bort, X. Ponsoda, E. Carrasco, M. Gomez-Lechon, and J. Castell Metabolism of aceclofenac in humans Drug Metab. Dispos. 24 1996 834 841 (Pubitemid 26274739)
11. C. Charnay, S. Begu, C. Tourn-Pateilh, L. Nicole, D.A. Lerner, and J.M. Devoisselle Inclusion of ibuprofen in mesoporous templated silica: drug loading and release property Eur. J. Pharm. Biopharm. 57 2004 533 540 (Pubitemid 38490572)
12. C. Charnay, S. Bégu, C. Tourné-Péteilh, L. Nicole, D.A. Lerner, and J.M. Devoisselle Inclusion of ibuprofen in mesoporous templated silica: drug loading and release property Eur. J. Pharm. Biopharm. 57 2004 533 540 (Pubitemid 38490572)
13. C.Y. Chen, S.L. Burkett, H.X. Li, and M.E. Davis Studies on mesoporous materials. II. Synthesis mechanism of MCM-41 Microporous Mater. 2 1993 27 34
14. U. Ciesla, and F. Schuth Ordered mesoporous materials Microporous Mesoporous Mater. 27 1999 131 149
15. P. Costa, and J.M. Sousa Lobo Modeling and comparison of dissolution profiles Eur. J. Pharm. Sci. 13 2001 123 133 (Pubitemid 32288781)
16. K. Dua, K. Pabreja, M.V. Ramana, and V. Lather Dissolution behavior of β-cyclodextrin molecular inclusion complexes of aceclofenac J. Pharm. Bioallied Sci. 3 2011 417
17. V. Fenelonov, V. Romannikov, and A.Y. Derevyankin Mesopore size and surface area calculations for hexagonal mesophases (types MCM-41, FSM-16, etc.) using low-angle XRD and adsorption data Microporous Mesoporous Mater. 28 1999 57 72
18. H. Friedrich, B. Fussnegger, K. Kolter, and R. Bodmeier Dissolution rate improvement of poorly water-soluble drugs obtained by adsorbing solutions of drugs in hydrophilic solvents onto high surface area carriers Eur. J. Pharm. Biopharm. 62 2006 171 177 (Pubitemid 43143269)
19. E. Gonzalez, C. De La Cruz, R. De Nicolás, J. Egido, and G. Herrero-Beaumont Long-term effect of nonsteroidal anti-inflammatory drugs on the production of cytokines and other inflammatory mediators by blood cells of patients with osteoarthritis Inflamm. Res. 41 1994 171 178
20. F. Hoffmann, M. Cornelius, J. Morell, and M. Fröba Silica-based mesoporous organic-inorganic hybrid materials Angew. Chem. Int. Ed. 45 2006 3216 3251 (Pubitemid 44098982)
21. P. Horcajada, A. Ramila, J. Perez-Pariente, and M. Vallet-Regi Influence of pore size of MCM-41 matrices on drug delivery rate Microporous Mesoporous Mater. 68 2004 105 109 (Pubitemid 38265756)
22. J. Hu, T.L. Rogers, J. Brown, T. Young, K.P. Johnston, and R.O. Williams Iii Improvement of dissolution rates of poorly water soluble APIs using novel spray freezing into liquid technology Pharm. Res. 19 2002 1278 1284
23. Q. Huo, D.I. Margolese, and G.D. Stucky Surfactant control of phases in the synthesis of mesoporous silica-based materials Chem. Mater. 8 1996 1147 1160 (Pubitemid 126467425)
24. K.A. Khan The concept of dissolution efficiency J. Pharm. Pharmacol. 27 1975 48 49
25. C. Leuner, and J. Dressman Improving drug solubility for oral delivery using solid dispersions Eur. J. Pharm. Biopharm. 50 2000 47 60 (Pubitemid 30326688)
26. G. Levy Effect of certain tablet formulation factors on dissolution rate of the active ingredient. I. Importance of using appropriate agitation intensities for in vitro dissolution rate measurements to reflect in vivo conditions J. Pharm. Sci. 52 1963 1039 1046
27. M. Luechinger, L. Frunz, G.D. Pirngruber, and R. Prins A mechanistic explanation of the formation of high quality MCM-41 with high hydrothermal stability Microporous Mesoporous Mater. 64 2003 203 211 (Pubitemid 37245345)
28. S. Madieh, M. Simone, W. Wilson, D. Mehra, and L. Augsburger Investigation of drug-porous adsorbent interactions in drug mixtures with selected porous adsorbents J. Pharm. Sci. 96 2007 851 863 (Pubitemid 46657873)
29. R. Mellaerts, C.A. Aerts, J. Van Humbeeck, P. Augustijns, G. Van den Mooter, and J.A. Martens Enhanced release of itraconazole from ordered mesoporous SBA-15 silica materials Chem. Commun. 2007 1375 1377 (Pubitemid 46465984)
30. P. Musmade, G. Subramanian, and K. Srinivasan High-performance liquid chromatography and pharmacokinetics of aceclofenac in rats Anal. Chim. Acta 585 2007 103 109 (Pubitemid 46176779)
31. S. Mutalik, P. Anju, K. Manoj, and A.N. Usha Enhancement of dissolution rate and bioavailability of aceclofenac: a chitosan-based solvent change approach Int. J. Pharm. Sci. 350 2008 279 290
32. S. Mutalik, A. Naha, A. Usha, A. Ranjith, P. Musmade, K. Manoj, P. Anju, and S. Prasanna Preparation, in vitro, preclinical and clinical evaluations of once daily sustained release tablets of aceclofenac Arch. Pharm. Res. 30 2007 222 234
33. J. Rouquerol, D. Avnir, C. Fairbridge, D. Everett, J. Haynes, N. Pernicone, J. Ramsay, K. Sing, and K. Unger Recommendations for the characterization of porous solids (technical report) Pure Appl. Chem. 66 1994 1739
34. A. Santomaso, P. Lazzaro, and P. Canu Powder flowability and density ratios: the impact of granules packing Chem. Eng. Sci. 58 2003 2857 2874 (Pubitemid 36837789)
35. K. Shaikh, and A. Devkhile Simultaneous determination of aceclofenac, paracetamol, and chlorzoxazone by RP-HPLC in pharmaceutical dosage form J. Chromatogr. Sci. 46 2008 649 652
36. K.S.W. Sing, D.H. Everett, R.A.W. Haul, L. Moscou, R.A. Peirotti, and J. Rouquerol IUPAC commission on colloid and surface chemistry including catalysis Pure Appl. Chem. 57 1985 603 619
37. T. Soni, C. Nagda, T. Gandhi, and N.P. Chotai Development of discriminating method for dissolution of aceclofenac marketed formulations Dissolut. Technol. 15 2008 31
38. S. Storck, H. Bretinger, and W.F. Maier Characterization of micro-and mesoporous solids by physisorption methods and pore-size analysis Appl. Catal. A 174 1998 137 146 (Pubitemid 128410806)
39. P.H.L. Tran, T.T.D. Tran, K.H. Lee, D.J. Kim, and B.J. Lee Dissolution-modulating mechanism of pH modifiers in solid dispersion containing weakly acidic or basic drugs with poor water solubility Expert. Opin. Drug Del. 7 2010 647 661
40. M. Van Speybroeck, R. Mellaerts, R. Mols, T.D. Thi, J.A. Martens, J. Van Humbeeck, P. Annaert, G. Van den Mooter, and P. Augustijns Enhanced absorption of the poorly soluble drug fenofibrate by tuning its release rate from ordered mesoporous silica Eur. J. Pharm. Sci. 41 2010 623 630
41. S. Wang Ordered mesoporous materials for drug delivery Microporous Mesoporous Mater. 117 2009 1 9
42. B. Yilmaz, A. Asci, and S.S. Palabiyik HPLC method for determination of diclofenac in human plasma and its application to a pharmacokinetic study in Turkey J. Chromatogr. Sci. 49 2011 422 427
43. L. Yin, F. Wang, and J. Fu Effects of post-synthesis treatments on the pore structure and stability of MCM-41 mesoporous silica Mater. Lett. 61 2007 3119 3123 (Pubitemid 46654313)
44. Y. Zhang, J. Zhang, T. Jiang, and S. Wang Inclusion of the poorly water-soluble drug simvastatin in mesocellular foam nanoparticles: drug loading and release properties Int. J. Pharm. 410 2011 118 124